Hoya Corp. (OTCMKTS:HOCPY – Get Free Report) gapped up prior to trading on Thursday. The stock had previously closed at $165.88, but opened at $173.13. Hoya shares last traded at $165.30, with a volume of 627 shares changing hands.
Wall Street Analyst Weigh In
Separately, Zacks Research raised Hoya from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, September 30th. One investment analyst has rated the stock with a Strong Buy rating. Based on data from MarketBeat.com, the company has a consensus rating of “Strong Buy”.
Get Our Latest Research Report on HOCPY
Hoya Price Performance
The company’s fifty day moving average price is $154.61 and its 200 day moving average price is $163.13. The company has a debt-to-equity ratio of 0.03, a quick ratio of 4.20 and a current ratio of 4.91. The firm has a market capitalization of $56.00 billion, a price-to-earnings ratio of 33.18, a price-to-earnings-growth ratio of 3.44 and a beta of 0.97.
Hoya (OTCMKTS:HOCPY – Get Free Report) last announced its quarterly earnings data on Friday, July 31st. The technology company reported $1.23 earnings per share for the quarter, beating analysts’ consensus estimates of $1.13 by $0.10. The business had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.55 billion. Hoya had a net margin of 27.58% and a return on equity of 25.78%. Equities research analysts expect that Hoya Corp. will post 5.26 earnings per share for the current year.
About Hoya
HOYA Corporation is a Japan-based technology and healthcare company that develops and manufactures optical products and precision components. Founded in 1941 as an optical glass manufacturer, the company has expanded into medical devices, vision care, and advanced technologies used in semiconductor production and other industrial applications.
Through its Life Care businesses, HOYA provides prescription eyeglass lenses, contact lenses, intraocular lenses used in cataract surgery, and medical equipment such as endoscopic systems.
See Also
- Five stocks we like better than Hoya
- Flywire’s Rapid Growth Faces a Q3 Test—Is Its Stock Already Too Expensive?
- Cologuard Is Working—So Why Isn’t Abbott Stock?
- Micron’s Taiwan Strike: A High-Stakes Fight Over AI Profits
- Intuitive Surgical Stock: Margin Hit Masks Strong Q3 Growth Story
Receive News & Ratings for Hoya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hoya and related companies with MarketBeat.com's FREE daily email newsletter.
